Cactus' accrual ratio and unusual items hint at conservative statutory earnings. Its underlying earnings power matches or surpasses statutory figures. Yet, a warning sign exists for Cactus. Its profit performance sparks optimism.
We Like Cactus' (NYSE:WHD) Earnings For More Than Just Statutory Profit
Analysts are more optimistic about BJ's Restaurants' earnings after recent results, expecting a significant EPS upgrade next year. Despite projected slower revenue growth, the increased price target indicates an improving intrinsic value.
Insider transactions over the past year indicate a bullish sentiment towards the company, despite shares being bought at a higher price than the current rate. However, increased insider ownership could better align with common shareholders.
Given the lack of positive returns and earnings growth, it's suggested that generous CEO pay would be unwise. The upcoming AGM is a chance for the board to discuss plans to boost performance.
Shareholders are unenthused about the future share price due to the company's low P/S ratio and slower revenue growth. The company's poor revenue outlook is contributing to its low P/S, and a change of fortune is needed for a higher P/S.
Medifast's low P/E ratio indicates poor earnings growth and the expectation of this trend persisting. The weak outlook is pressuring the share price, with no significant rise expected soon. Investors see insufficient potential for earnings improvement to justify a higher P/E ratio.
The EPS growth outshines the yearly share price gain of 12%. Despite the market's current lack of enthusiasm reflected in a low P/E ratio of 11.55, the positive returns over five years indicate continued market approval.
Insider selling at lower prices indicates satisfaction with a lower valuation. Lack of insider buying and history of sales, despite high ownership, raises concerns about future prospects.
Analysts are more optimistic about Revolve Group's earnings potential after recent results, leading to a consensus earnings per share upgrade. Despite expected slower revenue growth, the price target upgrade suggests analysts believe the business's intrinsic value will improve over time.
Analysts are more negative on ProAssurance after recent results, downgrading their EPS forecast for next year. The company's revenue is expected to slow, with a forecasted annual decline of 4.8% by 2024, a significant reduction from 5.5% annual growth over the last five years. This performance is expected to lag behind the industry's forecasted annual growth of 5.9%.